Filing Details
- Accession Number:
- 0001410939-22-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-04 16:09:58
- Reporting Period:
- 2022-08-02
- Accepted Time:
- 2022-08-04 16:09:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410939 | Iveric Bio Inc. | ISEE | Pharmaceutical Preparations (2834) | 208185347 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1877012 | Paul Christopher Simms | C/O Iveric Bio, Inc. 8 Sylvan Way Parsippany NJ 07054 | Svp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-02 | 15,000 | $0.00 | 22,069 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-08-02 | 18,750 | $0.00 | 40,819 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-03 | 5,454 | $11.25 | 35,365 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-08-03 | 6,818 | $11.25 | 28,547 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2022-08-02 | 15,000 | $0.00 | 15,000 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2022-08-02 | 18,750 | $0.00 | 18,750 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 56,250 | No | 4 | M | Direct |
Footnotes
- Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
- Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on August 2, 2022.
- The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions ranging from $11.14 to $11.38 per share on August 3, 2022 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees.
- Each restricted stock unit represents the contingent right to receive one share of common stock of the Registrant upon vesting of the unit.
- Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest with respect to 100% of the shares subject to the award on the first anniversary of the grant date.
- Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date.
Billionaire Hedge Funds
